Factors associated with breast cancer recurrences or mortality and dynamic prediction of death using history of cancer recurrences: the French E3N cohort

[1]  L. Baglietto,et al.  Factors associated with breast cancer recurrences or mortality and dynamic prediction of death using history of cancer recurrences: the French E3N cohort , 2018, BMC Cancer.

[2]  Virginie Rondeau,et al.  Tutorial in Joint Modeling and Prediction: a Statistical Software for Correlated Longitudinal Outcomes, Recurrent Events and a Terminal Event , 2017, 1701.03675.

[3]  Virginie Rondeau,et al.  Joint model for left‐censored longitudinal data, recurrent events and terminal event: Predictive abilities of tumor burden for cancer evolution with application to the FFCD 2000–05 trial , 2016, Biometrics.

[4]  J. Chang-Claude,et al.  Relationship between menopausal hormone therapy and mortality after breast cancer The MARIEplus study, a prospective case cohort , 2015, International journal of cancer.

[5]  F. Clavel-Chapelon.  Cohort Profile: The French E3N Cohort Study. , 2015, International journal of epidemiology.

[6]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[7]  V. McCormack,et al.  Active and passive cigarette smoking and breast cancer risk: Results from the EPIC cohort , 2014, International journal of cancer.

[8]  A. Chagpar,et al.  Smoking and Breast Cancer Recurrence after Breast Conservation Therapy , 2014, International journal of breast cancer.

[9]  X. Shu,et al.  Lifetime cigarette smoking and breast cancer prognosis in the After Breast Cancer Pooling Project. , 2014, Journal of the National Cancer Institute.

[10]  Virginie Rondeau,et al.  Dynamic prediction of risk of death using history of cancer recurrences in joint frailty models , 2013, Statistics in medicine.

[11]  Haifa Dbouk,et al.  Epidemiology and prognosis of breast cancer in young women. , 2013, Journal of thoracic disease.

[12]  Lihong Qi,et al.  Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study. , 2013, Journal of the National Cancer Institute.

[13]  F. Berrino,et al.  Fasting blood glucose and long-term prognosis of non-metastatic breast cancer: a cohort study , 2013, Breast Cancer Research and Treatment.

[14]  W. Willett,et al.  Alcohol consumption before and after breast cancer diagnosis: associations with survival from breast cancer, cardiovascular disease, and other causes. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  A. Tjønneland,et al.  Pre‐diagnostic alcohol consumption and breast cancer recurrence and mortality: Results from a prospective cohort with a wide range of variation in alcohol intake , 2013, International journal of cancer.

[16]  Virginie Rondeau,et al.  frailtypack: An R Package for the Analysis of Correlated Survival Data with Frailty Models Using Penalized Likelihood Estimation or Parametrical Estimation , 2012 .

[17]  M. Kerin,et al.  Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype , 2012, Breast Cancer Research and Treatment.

[18]  V. Rondeau,et al.  FRAILTYPACK : An R package for the analysis of correlated survival data with frailty models using the penalized likelihood estimation , 2011 .

[19]  C. Sweeney,et al.  Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the life after cancer epidemiology study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  J. Coebergh,et al.  An overview of prognostic factors for long-term survivors of breast cancer , 2007, Breast Cancer Research and Treatment.

[21]  Virginie Rondeau,et al.  Joint frailty models for recurring events and death using maximum penalized likelihood estimation: application on cancer events. , 2006 .

[22]  M. Rossing,et al.  Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients , 2007, Breast Cancer Research.

[23]  F. Roviello,et al.  Breast Cancer Local Recurrence: Risk Factors and Prognostic Relevance of Early Time to Recurrence , 2006, World Journal of Surgery.

[24]  F. Liebens,et al.  Influence of HRT on prognostic factors for breast cancer: a systematic review after the Women's Health Initiative trial. , 2004, Human reproduction.

[25]  Laurence L. George,et al.  The Statistical Analysis of Failure Time Data , 2003, Technometrics.

[26]  D. Commenges,et al.  Maximum Penalized Likelihood Estimation in a Gamma-Frailty Model , 2003, Lifetime data analysis.

[27]  J. Kalbfleisch,et al.  The Statistical Analysis of Failure Time Data: Kalbfleisch/The Statistical , 2002 .

[28]  J. Peterse,et al.  Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  P. Ravdin,et al.  Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  J. Kalbfleisch,et al.  The Statistical Analysis of Failure Time Data , 1980 .